Prescribing Information

Prescribing Information

 

Important Safety Information

In clinical trials (n=18,168), the most frequently reported adverse events included injection site reactions, fever ( 38ºC/100.4ºF), irritability, drowsiness, restless sleep, decreased appetite, vomiting, diarrhea, and rash.

Risks are associated with all vaccines, including Prevnar®. Hypersensitivity to any vaccine component, including diphtheria toxoid, is a contraindication to its use. Prevnar® does not provide 100% protection against vaccine serotypes or protect against nonvaccine serotypes.

Please see Prescribing Information

References:

1. Prescribing Information for Prevnar®, Pneumococcal 7-valent Conjugate Vaccine (Diphtheria CRM197 Protein). Wyeth Pharmaceuticals Inc.
2. Centers for Disease Control and Prevention. Recommended childhood and adolescent immunization schedule-United States, 2005. MMWR. 2005;53:Q1-Q3.

Back to Top